Aldeyra Therapeutics Inc. (NASDAQ: ALDX) Stock Information | RedChip

Aldeyra Therapeutics Inc. (NASDAQ: ALDX)


$4.9400
+0.0800 ( +2.70% ) 177.8K

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

Market Data


Open


$4.9400

Previous close


$4.8600

Volume


177.8K

Market cap


$290.60M

Day range


$4.6510 - $5.0250

52 week range


$2.7100 - $6.5476

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Mar 12, 2024
4 Insider transactions 1 Mar 12, 2024
4 Insider transactions 1 Mar 12, 2024
10-k Annual reports 89 Mar 07, 2024
8-k 8K-related 34 Feb 13, 2024
8-k 8K-related 13 Jan 04, 2024
8-k 8K-related 12 Dec 21, 2023
8-k 8K-related 33 Dec 19, 2023

Latest News